These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 5336542)
1. The use of human spleen imprints for routine testing for serum antinuclear factors by immunofluorescence. Svec KH Am J Clin Pathol; 1967 Apr; 47(4):432-9. PubMed ID: 5336542 [No Abstract] [Full Text] [Related]
2. [Routine immunofluorescence studies for demonstration of antinuclear factors]. Hiemann D Z Gesamte Inn Med; 1969 May; 24(10):150-1. PubMed ID: 4185287 [No Abstract] [Full Text] [Related]
3. [Antinuclear antibodies in systemic lupus erythematosus before and after treatment and in chronic progressive polyarthritis. Some observations on the antiperinuclear factor]. Marmont A; Damasio E J Belge Rhumatol Med Phys; 1967; 22(4):236-66. PubMed ID: 4185874 [No Abstract] [Full Text] [Related]
4. Two new antinuclear antibodies: their relationship to the homogeneous immunofluorescent pattern. Ritchie RF Arthritis Rheum; 1968 Feb; 11(1):37-43. PubMed ID: 4867854 [No Abstract] [Full Text] [Related]
6. [Routine immunofluorescence examinations for the demonstration of antinuclear factors]. Hiemann D Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:150-1. PubMed ID: 4918616 [No Abstract] [Full Text] [Related]
7. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology]. Kahn MF; Dryll A; de Seze S J Belge Rhumatol Med Phys; 1967; 22(4):217-30. PubMed ID: 4185873 [No Abstract] [Full Text] [Related]
12. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases]. Velasco M; Losada M; Losada A; Ramirez G Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546 [No Abstract] [Full Text] [Related]
13. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus]. Peltier AP Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383 [No Abstract] [Full Text] [Related]
14. Antinuclear antibodies. I. Patterns of nuclear immunofluorescence. Burnham TK; Bank PW J Invest Dermatol; 1974 May; 62(5):526-34. PubMed ID: 4595992 [No Abstract] [Full Text] [Related]
15. Natural antibody to procainamide and procainamide-induced systematic lupus erythematosus. Russel AS; Ziff M Ann Rheum Dis; 1969 May; 28(3):328. PubMed ID: 5305703 [No Abstract] [Full Text] [Related]
16. [Arthritis in definitive systemic lupus erythematosus]. Haberhauer G Z Arztl Fortbild (Jena); 1990; 84(3):85-7. PubMed ID: 2343605 [No Abstract] [Full Text] [Related]
17. [Antinuclear and perinuclear atibodies in rheumatology. Immunofluorescence studies]. Marmont A; Damasio E G Mal Infett Parassit; 1968 Jan; 20(1):124-32. PubMed ID: 4880275 [No Abstract] [Full Text] [Related]
18. Antinuclear antibodies in systemic lupus erythematosus. Detection with horseradish-peroxidase-conjugated antibody. Benson MD; Cohen AS Ann Intern Med; 1970 Dec; 73(6):943-9. PubMed ID: 4947942 [No Abstract] [Full Text] [Related]
19. A modified procedure for the detection of antinuclear factor using human leukocytes. Dreessen G; Haven G; Halbridge N Am J Clin Pathol; 1972 Apr; 57(4):463-6. PubMed ID: 4552044 [No Abstract] [Full Text] [Related]
20. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence. Burnham TK; Neblett TR; Fine G; Bank P Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089 [No Abstract] [Full Text] [Related] [Next] [New Search]